Predicate |
Object |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01K2217-075 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01K2217-05 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N9-1205 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N9-12 |
filingDate |
2001-06-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_742309a2165f5ffc052831f4ddf041d0 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d3ad85a46699709fc3197ec5e85aa96e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7cd55d32125a03921ede37d548f9279c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dffc66ebe1d841817fea356ca413688a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_20144368424cbe9637c1c1e27537fcc8 |
publicationDate |
2002-05-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-2002051786-A1 |
titleOfInvention |
Modulators of p85 expression |
abstract |
Methods of treating a subject having an insulin-related disorder, e.g., diabetes. The methods include reducing the amount of p85 P13K regulatory subunit isoform in a cell of the subject. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2003108883-A1 |
priorityDate |
2000-06-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |